Precigen, Inc.: what the price is pricing in
There is no current earnings reading for Precigen, Inc.: its latest is from March 31, 2024. Switch lens below to see the other readings and how trading the gap would have done.
No published rating for Precigen, Inc.: data-quality checks not passed. The readings below run our models backwards for research and show how trading the gap would have done; they are not a valuation or a rating. The valuation page shows the models and their status.
What growth in earnings is the price paying for?
No current reading. The latest is from March 31, 2024: the figures this lens needs have not been filed recently enough (or no longer apply), so there is no position this quarter.
Over time
$10,000 trading the gap vs the S&P 500
Skill or luck?
In plain English: With only 3 quarters of positions, Precigen, Inc.'s own record is too short to tell skill from luck. The results across all companies on the priced-in page are the better guide.
| Positions | Quarters | Beat the S&P 500 | Average vs S&P 500, a quarter | Typical (median), a quarter | A year | Confidence (t) | Evidence |
|---|---|---|---|---|---|---|---|
| Longs | 3 | 33.3% | −3.7% | −0.2% | −27.3% | -0.20 | Too few quarters |
| Shorts | 0 | — | — | — | — | — | — |
| All positions | 3 | 33.3% | −3.7% | −0.2% | −27.3% | -0.20 | Too few quarters |
Every quarter (6)
| From | Price paid | Growth the P/E implies | Growth our model assumes | Position | PGEN | S&P 500 |
|---|---|---|---|---|---|---|
| March 31, 2024 | $1.45 | -3.2% | 4.1% | No position | +9.0% | +4.4% |
| December 31, 2023 | $1.34 | -5.1% | 4.1% | No position | +8.2% | +10.4% |
| September 30, 2023 | $1.42 | -3.7% | 4.1% | No position | −5.6% | +11.6% |
| June 30, 2023 | $1.15 | -14.2% | 4.0% | Long | +23.5% | −3.2% |
| March 31, 2023 | $1.06 | -16.8% | 4.0% | Long | +8.5% | +8.7% |
| December 31, 2022 | $1.52 | -8.2% | 4.0% | Long | −30.3% | +7.5% |
What profit margin is the price paying for?
No current reading. The latest is from March 31, 2024: the figures this lens needs have not been filed recently enough (or no longer apply), so there is no position this quarter.
Over time
$10,000 trading the gap vs the S&P 500
Skill or luck?
In plain English: Across 34 quarters with a position, this lens beat the S&P 500 in 23, by +4.3% a quarter on average. That could easily be chance. One company is a small sample: the results across all companies are the better guide.
| Positions | Quarters | Beat the S&P 500 | Average vs S&P 500, a quarter | Typical (median), a quarter | A year | Confidence (t) | Evidence |
|---|---|---|---|---|---|---|---|
| Longs | 0 | — | — | — | — | — | — |
| Shorts | 34 | 67.6% | +4.3% | +15.5% | — | 0.59 | No reliable evidence |
| All positions | 34 | 67.6% | +4.3% | +15.5% | — | 0.59 | No reliable evidence |
Every quarter (34)
| From | Price paid | Margin the price implies | Margin delivered | Position | PGEN | S&P 500 |
|---|---|---|---|---|---|---|
| March 31, 2024 | $1.45 | 65.4% | -224.2% | Short | +9.0% | +4.4% |
| December 31, 2023 | $1.34 | 58.8% | -224.2% | Short | +8.2% | +10.4% |
| September 30, 2023 | $1.42 | 63.6% | -224.2% | Short | −5.6% | +11.6% |
| June 30, 2023 | $1.15 | 40.1% | -179.3% | Short | +23.5% | −3.2% |
| March 31, 2023 | $1.06 | 48.5% | -157.2% | Short | +8.5% | +8.7% |
| December 31, 2022 | $1.52 | 58.8% | -157.0% | Short | −30.3% | +7.5% |
| June 30, 2022 | $1.34 | 117.8% | -156.8% | Short | +58.2% | −4.9% |
| March 31, 2022 | $2.11 | 78.3% | -162.5% | Short | −36.5% | −16.1% |
| December 31, 2021 | $3.71 | 87.2% | -153.5% | Short | −43.1% | −4.6% |
| September 30, 2021 | $4.99 | 81.5% | -147.6% | Short | −25.6% | +11.1% |
| June 30, 2021 | $6.52 | 74.6% | -141.0% | Short | −23.5% | +0.6% |
| March 31, 2021 | $6.89 | 69.3% | -144.3% | Short | −5.4% | +8.4% |
| December 31, 2020 | $10.20 | 94.2% | -132.3% | Short | −32.5% | +6.3% |
| September 30, 2020 | $3.50 | 37.4% | -130.9% | Short | +191.4% | +12.1% |
| June 30, 2020 | $4.99 | 47.8% | -124.4% | Short | −29.9% | +9.0% |
| March 31, 2020 | $3.40 | 39.8% | -119.7% | Short | +46.8% | +20.2% |
| December 31, 2019 | $5.48 | 45.5% | -113.2% | Short | −38.0% | −19.4% |
| September 30, 2019 | $5.72 | 41.0% | -106.6% | Short | −4.2% | +9.0% |
| June 30, 2019 | $7.66 | 48.2% | -99.3% | Short | −25.3% | +1.8% |
| March 31, 2019 | $5.26 | 24.8% | -88.8% | Short | +45.6% | +4.2% |
| December 31, 2018 | $6.54 | 25.8% | -79.9% | Short | −19.6% | +13.5% |
| September 30, 2018 | $17.22 | 48.6% | -62.7% | Short | −62.0% | −13.5% |
| June 30, 2018 | $13.94 | 26.6% | -59.2% | Short | +23.5% | +7.7% |
| March 31, 2018 | $15.33 | 25.2% | -55.1% | Short | −9.1% | +3.5% |
| December 31, 2017 | $11.52 | 21.1% | -52.4% | Short | +33.1% | −1.0% |
| September 30, 2017 | $19.01 | 34.2% | -48.0% | Short | −39.4% | +6.8% |
| June 30, 2017 | $24.09 | 43.3% | -46.9% | Short | −21.1% | +4.4% |
| March 31, 2017 | $19.82 | 36.1% | -42.3% | Short | +21.5% | +3.1% |
| December 31, 2016 | $24.08 | 45.6% | -39.2% | Short | −17.7% | +5.9% |
| September 30, 2016 | $27.77 | 51.3% | -38.4% | Short | −13.3% | +4.0% |
| June 30, 2016 | $24.39 | 46.0% | -40.9% | Short | +13.9% | +3.8% |
| March 31, 2016 | $33.59 | 67.6% | -44.7% | Short | −27.4% | +2.5% |
| December 31, 2015 | $29.88 | 62.6% | -55.9% | Short | +12.4% | +1.3% |
| September 30, 2015 | $31.52 | 81.5% | -102.5% | Short | −5.2% | +7.0% |
What return on equity is the price paying for?
No current reading. The latest is from March 31, 2024: the figures this lens needs have not been filed recently enough (or no longer apply), so there is no position this quarter.
Over time
$10,000 trading the gap vs the S&P 500
Skill or luck?
In plain English: Across 21 quarters with a position, this lens beat the S&P 500 in 12, by +8.3% a quarter on average. That could easily be chance. One company is a small sample: the results across all companies are the better guide.
| Positions | Quarters | Beat the S&P 500 | Average vs S&P 500, a quarter | Typical (median), a quarter | A year | Confidence (t) | Evidence |
|---|---|---|---|---|---|---|---|
| Longs | 3 | 33.3% | +8.1% | −0.2% | +32.8% | 0.87 | Too few quarters |
| Shorts | 18 | 61.1% | +8.3% | +14.9% | +13.6% | 1.17 | No reliable evidence |
| All positions | 21 | 57.1% | +8.3% | +12.6% | +16.2% | 1.35 | No reliable evidence |
Every quarter (24)
| From | Price paid | Return on equity the price implies | Return on equity delivered | Position | PGEN | S&P 500 |
|---|---|---|---|---|---|---|
| March 31, 2024 | $1.45 | 15.5% | 20.0% | No position | +9.0% | +4.4% |
| December 31, 2023 | $1.34 | 14.5% | 20.0% | Long | +8.2% | +10.4% |
| September 30, 2023 | $1.42 | 15.2% | 20.0% | No position | −5.6% | +11.6% |
| June 30, 2023 | $1.15 | 11.1% | 19.3% | Long | +23.5% | −3.2% |
| March 31, 2023 | $1.06 | 12.6% | 24.2% | Long | +8.5% | +8.7% |
| December 31, 2022 | $1.52 | 15.3% | 18.6% | No position | −30.3% | +7.5% |
| September 30, 2022 | $2.12 | 48.3% | -85.3% | Short | −28.3% | +7.6% |
| June 30, 2022 | $1.34 | 24.2% | -75.7% | Short | +58.2% | −4.9% |
| December 31, 2018 | $6.54 | 11.9% | -36.6% | Short | −19.6% | +13.5% |
| September 30, 2018 | $17.22 | 26.8% | -32.4% | Short | −62.0% | −13.5% |
| June 30, 2018 | $13.94 | 19.8% | -23.0% | Short | +23.5% | +7.7% |
| March 31, 2018 | $15.33 | 23.3% | -21.4% | Short | −9.1% | +3.5% |
| December 31, 2017 | $11.52 | 18.1% | -23.6% | Short | +33.1% | −1.0% |
| September 30, 2017 | $19.01 | 27.3% | -21.1% | Short | −39.4% | +6.8% |
| June 30, 2017 | $24.09 | 35.0% | -25.7% | Short | −21.1% | +4.4% |
| March 31, 2017 | $19.82 | 27.7% | -29.8% | Short | +21.5% | +3.1% |
| December 31, 2016 | $24.08 | 31.0% | -26.6% | Short | −17.7% | +5.9% |
| September 30, 2016 | $27.77 | 34.3% | -33.7% | Short | −13.3% | +4.0% |
| June 30, 2016 | $24.39 | 28.2% | -27.0% | Short | +13.9% | +3.8% |
| March 31, 2016 | $33.59 | 35.8% | -15.7% | Short | −27.4% | +2.5% |
| December 31, 2015 | $29.88 | 30.5% | -6.1% | Short | +12.4% | +1.3% |
| September 30, 2015 | $31.52 | 46.0% | -11.2% | Short | −5.2% | +7.0% |
| June 30, 2015 | $48.36 | 51.5% | -11.1% | Short | −34.8% | −6.4% |
| March 31, 2015 | $43.36 | 69.2% | -21.8% | Short | +11.5% | +0.2% |
How the test works
At each quarter end since March 2010 we rebuild the models from Precigen, Inc.'s quarters ending at least 90 days earlier (and no more than 200 days before that), using the figures as later filed, including any restatement, and value them at that day's close, adjusted for later share splits and spin-offs so that price and share count are on the same basis. A wide enough gap is a long or a short for one quarter (growth 10 points; margin and return on equity 5 points; a PEG under 0.75 or over 3), measured on total return against the S&P 500. The rules were set before the test. No trading or borrowing costs; today's list of companies. Not investment advice. All companies and the results across them.
Compare with peers
- Janux Therapeutics, Inc. priced in
- Crispr Therapeutics AG priced in
- Scynexis Inc priced in
- Abeona Therapeutics Inc. priced in
- Celularity Inc priced in
Head to head: JANX vs PGENCRSP vs PGENPGEN vs SCYX
More: Biotechnology stocks compared, Health Care sector, rankings of US companies